Susan H.  Tousi net worth and biography

Susan Tousi Biography and Net Worth

SVP of Illumina
Susan H. Tousi is the Chief Product Officer at Illumina Inc.

What is Susan H. Tousi's net worth?

The estimated net worth of Susan H. Tousi is at least $5.14 million as of August 22nd, 2023. Ms. Tousi owns 45,524 shares of Illumina stock worth more than $5,141,481 as of December 10th. This net worth evaluation does not reflect any other investments that Ms. Tousi may own. Additionally, Ms. Tousi receives an annual salary of $790,200.00 as SVP at Illumina. Learn More about Susan H. Tousi's net worth.

How old is Susan H. Tousi?

Ms. Tousi is currently 54 years old. There are 6 older executives and no younger executives at Illumina. The oldest executive at Illumina is Mr. Charles E. Dadswell Esq., Senior VP & General Counsel, who is 64 years old. Learn More on Susan H. Tousi's age.

What is Susan H. Tousi's salary?

As the SVP of Illumina, Inc., Ms. Tousi earns $790,200.00 per year. The highest earning executive at Illumina is Mr. Charles E. Dadswell Esq., Senior VP & General Counsel, who commands a salary of $1,060,000.00 per year. Learn More on Susan H. Tousi's salary.

How do I contact Susan H. Tousi?

The corporate mailing address for Ms. Tousi and other Illumina executives is 200 ILLUMINA WAY, SAN DIEGO CA, 92122. Illumina can also be reached via phone at (858) 202-4500 and via email at [email protected]. Learn More on Susan H. Tousi's contact information.

Has Susan H. Tousi been buying or selling shares of Illumina?

Susan H. Tousi has not been actively trading shares of Illumina over the course of the past ninety days. Most recently, Susan H. Tousi sold 500 shares of the business's stock in a transaction on Tuesday, August 22nd. The shares were sold at an average price of $167.04, for a transaction totalling $83,520.00. Following the completion of the sale, the senior vice president now directly owns 45,524 shares of the company's stock, valued at $7,604,328.96. Learn More on Susan H. Tousi's trading history.

Who are Illumina's active insiders?

Illumina's insider roster includes Alexander Aravanis (SVP), Frances Arnold (Director), Charles Dadswell (SVP), Francis deSouza (CEO), Phillip Febbo (SVP), Jay Flatley (Director), Aimee Hoyt (SVP), Karen Mcginnis (CAO), Robert Ragusa (SVP), Mostafa Ronaghi (SVP), Sam Samad (CFO), Susan Tousi (SVP), and Mark Van Oene (SVP). Learn More on Illumina's active insiders.

Are insiders buying or selling shares of Illumina?

In the last year, insiders at the life sciences company sold shares 9 times. They sold a total of 13,001 shares worth more than $2,569,941.61. The most recent insider tranaction occured on November, 7th when SVP Aimee L Hoyt sold 315 shares worth more than $35,544.60. Insiders at Illumina own 0.1% of the company. Learn More about insider trades at Illumina.

Information on this page was last updated on 11/7/2023.

Susan H. Tousi Insider Trading History at Illumina

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/22/2023Sell500$167.04$83,520.0045,524View SEC Filing Icon  
7/24/2023Sell500$190.08$95,040.0046,022View SEC Filing Icon  
6/22/2023Sell500$200.00$100,000.0046,522View SEC Filing Icon  
2/6/2023Sell500$211.57$105,785.0038,276View SEC Filing Icon  
1/6/2023Sell500$204.58$102,290.0038,662View SEC Filing Icon  
12/6/2022Sell500$212.63$106,315.0039,162View SEC Filing Icon  
11/7/2022Sell500$223.65$111,825.0040,112View SEC Filing Icon  
10/6/2022Sell500$216.59$108,295.0041,333View SEC Filing Icon  
6/10/2022Sell250$214.85$53,712.5041,833View SEC Filing Icon  
1/12/2022Sell800$425.00$340,000.00View SEC Filing Icon  
12/28/2021Sell100$387.06$38,706.00View SEC Filing Icon  
12/8/2021Sell100$375.00$37,500.00View SEC Filing Icon  
10/28/2021Sell100$414.35$41,435.00View SEC Filing Icon  
9/28/2021Sell100$418.04$41,804.00View SEC Filing Icon  
8/30/2021Sell300$463.50$139,050.0041,456View SEC Filing Icon  
8/4/2021Sell1,000$500.00$500,000.00View SEC Filing Icon  
7/28/2021Sell300$486.41$145,923.0042,743View SEC Filing Icon  
6/28/2021Sell300$478.95$143,685.00View SEC Filing Icon  
5/20/2021Sell500$400.00$200,000.0043,343View SEC Filing Icon  
5/5/2021Sell300$381.88$114,564.0043,843View SEC Filing Icon  
3/5/2021Sell800$402.24$321,792.0044,943View SEC Filing Icon  
1/20/2021Sell2,500$400.00$1,000,000.0040,447View SEC Filing Icon  
1/5/2021Sell300$365.27$109,581.0042,947View SEC Filing Icon  
12/7/2020Sell300$349.34$104,802.0043,547View SEC Filing Icon  
12/4/2020Sell200$350.00$70,000.0043,547View SEC Filing Icon  
10/12/2020Sell200$350.00$70,000.0044,968View SEC Filing Icon  
10/7/2020Sell100$325.00$32,500.0045,168View SEC Filing Icon  
9/8/2020Sell100$336.00$33,600.0045,468View SEC Filing Icon  
8/5/2020Sell800$399.03$319,224.00View SEC Filing Icon  
7/20/2020Sell500$400.00$200,000.0046,354View SEC Filing Icon  
7/6/2020Sell300$375.00$112,500.0046,854View SEC Filing Icon  
5/28/2020Sell600$375.00$225,000.0047,154View SEC Filing Icon  
5/20/2020Sell300$350.00$105,000.0047,754View SEC Filing Icon  
5/12/2020Sell600$325.00$195,000.0048,054View SEC Filing Icon  
1/6/2020Sell200$325.00$65,000.0038,465View SEC Filing Icon  
See Full Table

Susan H. Tousi Buying and Selling Activity at Illumina

This chart shows Susan H Tousi's buying and selling at Illumina by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Illumina Company Overview

Illumina logo
Illumina, Inc. develops, manufactures, and markets life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through Core Illumina and GRAIL segments. The company offers sequencing and array-based instruments and consumables, which include reagents, flow cells, and library preparation; and whole-genome sequencing kits, which sequence entire genomes of any size and complexity, and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. Further, it provides whole-genome sequencing, genotyping, NIPT, and product support services; and Galleri, a multi-cancer early detection test. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. Further, it markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as sells through life-science distributors in various markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and Africa. Illumina, Inc. was incorporated in 1998 and is headquartered in San Diego, California.
Read More

Today's Range

Now: $112.94
Low: $112.90
High: $117.52

50 Day Range

MA: $113.97
Low: $92.79
High: $140.02

2 Week Range

Now: $112.94
Low: $89.00
High: $238.55


2,338,832 shs

Average Volume

3,747,339 shs

Market Capitalization

$17.93 billion

P/E Ratio


Dividend Yield